Results found for biontech | Eastern NC Now

Your source for all Eastern NC Events, Issues, Business, News and Information, Government, Politics, People, and Arts. Everything a tourist, and others alike need.

ENCNow
Home
Categories
Login
Advertisement
VbAD0
Latest Polls   (view all)
Where do you stand on the Transgender Issue now that the issue has gotten to the overt point of the open celebration of this lifestyle choice, dictated by certain direct and explicit actions.
91.07% I do not approve of behavior that has within its expressed tenants policies that harm children.
8.04% I do support the Trans Community in all its many facets because diversity is at a premium in today's society.
0.89% What is a "Children's Drag Queen Story Hour?"
Advertisement
VbAD1
Latest Comments   (view all)
Advertisement
VbAD2
Latest Entries   (view all)
Advertisement
VbAD3
ENCN Masthead
ENCN Masthead

Results found for "biontech"


Biopharmaceutical giant Moderna is filing a lawsuit against Pfizer-BioNTech in U.S. and German courts on Friday, alleging patent infringements in the development of its mRNA-based COVID vaccine.
Biopharmaceutical giant Moderna is filing a lawsuit against Pfizer-BioNTech in U.S. and German courts on Friday, alleging patent infringements in the development of its mRNA-based COVID vaccine.
 
Wednesday, the FDA authorized both the Moderna and Pfizer-BioNTech bivalent COVID-19 booster dose, which protects against the original as well as the Omicron strain.
Published: Monday, September 5th, 2022 @ 8:49 pm By: ENC NOW
Wednesday, the FDA authorized both the Moderna and Pfizer-BioNTech bivalent COVID-19 booster dose, which protects against the original as well as the Omicron strain.
 
Pfizer and BioNTech have requested that the Food and Drug Administration (FDA) grant an emergency use authorization for its COVID vaccine adapted to the BA.4/BA.5 versions of the Omicron variant.
Pfizer and BioNTech have requested that the Food and Drug Administration (FDA) grant an emergency use authorization for its COVID vaccine adapted to the BA.4/BA.5 versions of the Omicron variant.
 
On May 20th, the Centers for Disease Control and Prevention (CDC), in addition to the FDA, recommended a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 to 11.
On May 20th, the Centers for Disease Control and Prevention (CDC), in addition to the FDA, recommended a booster dose of the Pfizer-BioNTech COVID-19 vaccine for children between the ages of 5 to 11.
 
A new report states that the Biden administration’s Food and Drug Administration is pushing Pfizer and its partner, BioNTech to request emergency-use authorization for a vaccine for children as young as six months.
Published: Friday, February 18th, 2022 @ 8:58 pm By: Daily Wire
A new report states that the Biden administration’s Food and Drug Administration is pushing Pfizer and its partner, BioNTech to request emergency-use authorization for a vaccine for children as young as six months.
 
Children ages 5 to 11 can now receive a safe and effective COVID-19 vaccine.
Children ages 5 to 11 can now receive a safe and effective COVID-19 vaccine.
 
To strengthen and extend protections against severe illness, North Carolinians at high risk for serious illness or exposure who have been fully vaccinated with the Pfizer-BioNTech (COMINARTY) vaccine for six months or more can now receive a COVID-19 booster shot.
To strengthen and extend protections against severe illness, North Carolinians at high risk for serious illness or exposure who have been fully vaccinated with the Pfizer-BioNTech (COMINARTY) vaccine for six months or more can now receive a COVID-19 booster shot.
 
Advisors to the Food and Drug Administration (FDA) announced today the Pfizer-BioNTech (COMIRNATY) COVID-19 booster shot is safe, effective and recommended.
Advisors to the Food and Drug Administration (FDA) announced today the Pfizer-BioNTech (COMIRNATY) COVID-19 booster shot is safe, effective and recommended.
 
Like the Pfizer-BioNTech and Moderna vaccines, the Johnson & Johnson (J&J) vaccine protects against virus-related hospitalization and death.
Like the Pfizer-BioNTech and Moderna vaccines, the Johnson & Johnson (J&J) vaccine protects against virus-related hospitalization and death.
 
Pfizer Inc. and BioNTech SE have released new research and data that shows the COVID-19 vaccine they developed creates high immunity after only one dose and can be successfully stored in regular freezers rather than ultracold temperatures.
Published: Monday, February 22nd, 2021 @ 12:46 am By: Daily Wire
Pfizer Inc. and BioNTech SE have released new research and data that shows the COVID-19 vaccine they developed creates high immunity after only one dose and can be successfully stored in regular freezers rather than ultracold temperatures.
 
Stock markets surged at opening Monday after Pfizer and BioNTech announced that a vaccine candidate has a more than 90% effectiveness rate preventing COVID-19.
Stock markets surged at opening Monday after Pfizer and BioNTech announced that a vaccine candidate has a more than 90% effectiveness rate preventing COVID-19.
 

HbAD0

 
 
Back to Top